Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexmedetomidine
Drug ID BADD_D00629
Description An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Indications and Usage For sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting, also used in pain relief; anxiety reduction and analgesia
Marketing Status Prescription
ATC Code N05CM18
DrugBank ID DB00633
KEGG ID D00514
MeSH ID D020927
PubChem ID 5311068
TTD Drug ID D0U3DU
NDC Product Code 55150-209; 66794-230; 70860-605; 62068-308; 71872-7150; 66794-238; 66794-233; 16729-432; 71288-505; 67457-251; 16729-239
Synonyms Dexmedetomidine | MPV-1440 | MPV 1440 | MPV1440 | Precedex | Dexmedetomidine Hydrochloride | Hydrochloride, Dexmedetomidine
Chemical Information
Molecular Formula C13H16N2
CAS Registry Number 113775-47-6
SMILES CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Electrocardiogram ST segment elevation13.14.05.0250.000602%Not Available
Electrocardiogram T wave inversion13.14.05.007--Not Available
Electrolyte imbalance14.05.01.002--Not Available
Extrasystoles02.03.02.003--Not Available
Extravasation08.01.03.0080.001204%Not Available
Feeling abnormal08.01.09.014--Not Available
Fluid overload14.05.06.001; 02.05.04.004--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Gamma-glutamyltransferase increased13.03.01.011--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema14.05.06.007; 08.01.07.004--
Generalised tonic-clonic seizure17.12.01.0020.000903%Not Available
Haematocrit decreased13.01.05.0010.001204%Not Available
Haemoglobin13.01.05.018--Not Available
Haemoglobin decreased13.01.05.0030.001204%Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Heart rate decreased13.14.04.0010.001806%Not Available
Heart rate increased13.14.04.0020.000602%Not Available
Hepatic function abnormal09.01.02.001--Not Available
Hiccups22.02.04.002; 07.01.06.0090.001204%
Hyperbilirubinaemia14.11.01.010; 09.01.01.003; 01.06.04.003--Not Available
Hypercapnia22.02.02.002; 14.01.04.001--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkalaemia14.05.03.001--
Hypernatraemia14.05.04.0010.001806%
Hyperpyrexia08.05.02.002--Not Available
Hypertension24.08.02.0010.000903%
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 7 Pages